David J. Wambeke SEC EDGAR Filings (CIK 0001971798)

SEC EDGAR filings, ownership reports, and insider transactions for David J. Wambeke.

Business address
C/O Diamedica Therapeutics Inc., 301 Carlson Parkway, Suite 210, Minneapolis, MN, 55305
Top holdings (ownership)
DMAC and NMTC
Get insider transactions for this reporting owner
David J. Wambeke has filed 6 SEC EDGAR filings since 11 Apr 2023

Latest Filings

Recent SEC filings for David J. Wambeke including 4, 3.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 03 Jun 2025 01 Jun 2025 001-36291
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 03 Jun 2024 01 Jun 2024 001-36291
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 16 Nov 2023 16 Nov 2023 001-36291
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 26 Jun 2023 23 Jun 2023 001-36291
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 11 Apr 2023 10 Apr 2023 001-36291
3 Open 3 document View SEC filing for 3 PRIMARY DOCUMENT 11 Apr 2023 10 Apr 2023 001-36291

About this filer

David J. Wambeke files with the SEC under CIK 0001971798. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages